Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders

NCT07824102 is registered in ClinicalTrials.gov with Martin Blomberg Jensen as lead sponsor.

NCT NCT07824102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07824102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
Lead sponsor
Martin Blomberg Jensen
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
December 31, 2045
Enrollment
20,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal gland disease, hypercalcemia, osteoporosis, pituitary disease, primary hyperparathyroidism, thyroid diseases